Clinical features and natural course of acromegaly in patients with discordance in the nadir GH level on the oral glucose test and the IGF-1 value at 3 months after adenomectomy
暂无分享,去创建一个
K. Sugiyama | K. Kurisu | K. Arita | A. Tominaga | Yasuyuki Kinoshita | Satoshi Usui | Tetsuhiko Sakoguchi
[1] K. Chihara,et al. Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method. , 2012, Endocrine journal.
[2] L. Boero,et al. Comparison of two immunoassays in the determination of IGF-I levels and its correlation with oral glucose tolerance test (OGTT) and with clinical symptoms in acromegalic patients , 2012, Pituitary.
[3] D. Clemmons. Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. , 2011, Clinical chemistry.
[4] P. Chanson,et al. A consensus on criteria for cure of acromegaly. , 2010, The Journal of clinical endocrinology and metabolism.
[5] A. Barkan,et al. Basal, but not pulsatile, growth hormone secretion determines the ambient circulating levels of insulin-like growth factor-I. , 2010, The Journal of clinical endocrinology and metabolism.
[6] A. Barkan,et al. Basal, But Not Pulsatile, Growth Hormone Secretion Determines the Ambient Circulating Levels of Insulin-Like Growth Factor-I , 2010 .
[7] M. Bidlingmaier,et al. Measurement of human growth hormone by immunoassays: current status, unsolved problems and clinical consequences. , 2010, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[8] J. Frystyk,et al. The current status of IGF-I assays--a 2009 update. , 2010, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[9] H. Machado,et al. Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity. , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[10] P. Freda. Monitoring of acromegaly: what should be performed when GH and IGF‐1 levels are discrepant? , 2009, Clinical endocrinology.
[11] A. Pontecorvi,et al. Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly. , 2009, The Journal of clinical endocrinology and metabolism.
[12] S. Melmed,et al. The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly. , 2009, The Journal of clinical endocrinology and metabolism.
[13] M. Gadelha,et al. Prevalence of discordant GH and IGF-I levels in acromegalics at diagnosis, after surgical treatment and during treatment with octreotide LAR. , 2008, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[14] G. Vargas,et al. Clinical and biochemical impact of the d3 growth hormone receptor genotype in acromegaly. , 2008, The Journal of clinical endocrinology and metabolism.
[15] B. Velkeniers,et al. Divergence between growth hormone and insulin-like growth factor-i concentrations in the follow-up of acromegaly. , 2008, The Journal of clinical endocrinology and metabolism.
[16] K. Ho,et al. Modulation of growth hormone action by sex steroids , 2006, Clinical endocrinology.
[17] F. Esposito,et al. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly , 2006, Clinical endocrinology.
[18] M. Bidlingmaier,et al. Postoperative evaluation of patients with acromegaly: clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levels. , 2005, The Journal of clinical endocrinology and metabolism.
[19] P. Cappabianca,et al. Effect of gender and gonadal status on the long‐term response to somatostatin analogue treatment in acromegaly , 2005, Clinical endocrinology.
[20] M. Sheppard. The critical parameters in GH excess. , 2005, Journal of endocrinological investigation.
[21] L. Essioux,et al. A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone , 2004, Nature Genetics.
[22] S. Ferris,et al. Variability and reliability of single serum IGF-I measurements: impact on determining predictability of risk ratios in disease development. , 2004, The Journal of clinical endocrinology and metabolism.
[23] G. Heinze,et al. Use of the oral glucose tolerance test to define remission in acromegaly. , 2003, Metabolism: clinical and experimental.
[24] S. O'dwyer,et al. Gender and age influence the relationship between serum GH and IGF‐I in patients with acromegaly , 2002, Clinical endocrinology.
[25] F. Casanueva,et al. Criteria for cure of acromegaly: a consensus statement. , 2000, The Journal of clinical endocrinology and metabolism.
[26] C. Matula,et al. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. , 1993, Neurosurgery.